Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

256.38
BATS BZX Real-Time Price
As of 1:07pm ET
 -3.86 / -1.48%
Today’s Change
195.50
Today|||52-Week Range
340.34
-17.96%
Year-to-Date
Allergan (AGN) Stock Is Thursday's 'Chart of the Day'
12:08pm / TheStreet.com - Paid Partner Content
Synergy Pharma Offers Suitors Lots of Synergy
Jul 22 / TheStreet.com - Paid Partner Content
Allergan Cures Its Ailing Chart
10:04am / TheStreet.com - Paid Partner Content
Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal
Jul 21 / TheStreet.com - Paid Partner Content
Jerome Dodson's Best Investments
Jul 27 / GuruFocus News - Paid Partner Content
Teva taps euro bond market ahead of ECB meeting
Jul 20 / FT.com - Paid Partner Content
Daniel Loeb's Third Point 2nd-Quarter 2016 Investor Letter
Jul 27 / GuruFocus News - Paid Partner Content
What Awaits Boston Scientific (BSX) in Q2 Earnings?
Jul 19 / Zacks.com - Paid Partner Content
3 Stocks Improving Performance Of The Health Care Sector
Jul 26 / TheStreet.com - Paid Partner Content
Hologic (HOLX) Q3 Earnings: A Surprise in the Cards?
Jul 19 / Zacks.com - Paid Partner Content
Jerome Dodson Comments on Allergan
Jul 26 / GuruFocus News - Paid Partner Content
Illumina (ILMN) to Report Q2 Earnings: What's in the Cards?
Jul 19 / Zacks.com - Paid Partner Content
Jerome Dodson's Parnassus Fund 2nd Quarter Commentary
Jul 26 / GuruFocus News - Paid Partner Content
Edwards Lifesciences (EW) Q2 Earnings: Will It Be a Miss?
Jul 18 / Zacks.com - Paid Partner Content
Jim Cramer -- I Agree With the Analysts on Gap, Allergan
Jul 25 / TheStreet.com - Paid Partner Content
Teva finalises bond sale of up to $16bn
Jul 18 / FT.com - Paid Partner Content
5 Incredibly Cheap Big Pharma Stocks
Jul 25 / MotleyFool.com - Paid Partner Content
Top 7 Research Reports for July 15, 2016
Jul 15 / Zacks.com - Paid Partner Content
Analysts' Actions -- Allergan, Alaska Air, Tableau, PulteGroup and More
Jul 25 / TheStreet.com - Paid Partner Content
Teva (TEVA) Provides 2016-2019 Outlook, Shares Gain
Jul 14 / Zacks.com - Paid Partner Content
Biogen Should Either a Buyer or a Seller Be
Jul 22 / TheStreet.com - Paid Partner Content
Shire boosted by FDA approval of dry eye drug
Jul 12 / FT.com - Paid Partner Content
Synergy Pharma Offers Lots of Synergies
Jul 22 / TheStreet.com - Paid Partner Content
20 stocks to buy after Brexit chaos
Jun 28 / CNNMoney.com